ArticleJACC. CardioOncology2026

REPLY: Reframing Mechanistic and Clinical Paradigms of Osimertinib-Associated Cardiotoxicity.

Yuta Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.